Patrick J. Strollo, MD

Patrick J. Strollo, MD, from the University of Pittsburgh Medical Center

Articles by Patrick J. Strollo, MD

What the Phase 3 AD109 Data Mean for Sleep Apnea, With Patrick John Strollo, MD

ByPatrick J. Strollo, MD

May 20th 2026

This interview at ATS highlights key takeaways regarding new phase 3 data on AD109 for obstructive sleep apnea (OSA).

AD109 Effective as Oral Agent for Obstructive Sleep Apnea, With Patrick John Strollo, MD

ByPatrick J. Strollo, MD

May 19th 2026

This interview at ATS 2026 highlights notable findings on the once-nightly oral pill, AD109, in obstructive sleep apnea (OSA).

HCPLive Five at SLEEP 2025

ByPeter Colvonen, PhD,John W. Winkelman, MD, PhD,Chenlu Gao, PhD,Patrick J. Strollo, MD,Danny Eckert, PhD

June 25th 2025

Check out the top 5 interviews from SLEEP 2025.

Patrick Strollo, MD I Credit: University of Pittsburgh

AD109 Improves OSA in Phase 3 SynAIRgy Trial, With Patrick Strollo, MD

ByPatrick J. Strollo, MD

June 19th 2025

At SLEEP 2025, HCPLive spoke to Strollo about the phase 3 SynAIRgy trial which evaluated AD109, a first-in-class, once-daily oral neuromuscular modulator, for OSA.

Patrick J. Strollo, MD

Articles by Patrick J. Strollo, MD

What the Phase 3 AD109 Data Mean for Sleep Apnea, With Patrick John Strollo, MD

AD109 Effective as Oral Agent for Obstructive Sleep Apnea, With Patrick John Strollo, MD

HCPLive Five at SLEEP 2025

AD109 Improves OSA in Phase 3 SynAIRgy Trial, With Patrick Strollo, MD

Latest Updated Articles

Trending on HCPLive

SimpleScreen CRC Blood Test Meets Endpoints in Clinical Validation Study

Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B

Eplontersen Misses Primary Endpoint in Phase 3 ATTR-CM Trial

Biologic Therapy for Asthma and COPD: Real-World Perspectives From APPs

What Are the Side Effects of Hair and Skin Supplements in Dermatology? With Rajani Katta, MD